Giovanni Botten, MD, PhD

Aspiring Pathologist Scientist 🔬
PGY-1 @UCLA_Pathology

Views are my own.

[Blood Journals Portfolio @BloodPortfolio]

Primary large B-cell lymphomas of immune-privileged sites
https://t.co/5oL4DHWkQ4 #lymphoidneoplasia

[Nico Gagelmann @NicoGagelmann]

What academics always dream of but never dare

[Ana Colino, MD @AMColinoG]

Progressive transformation of germinal centers #PathTwitter
- Characterized by enlarged nodal lymphoid follicles with ingress of mantle zone B cells into the germinal centers.
- Associated with previous, concurrent or subsequent lymphoma, particularly NLPHL.

[Cancer Cell @Cancer_Cell]

The hallmarks of cancer immune evasion https://t.co/zH5I9C7qoQ

[American Board of Pathology @TheABPath]

The draft Content Specifications for certification exams are open for public review. Residents & fellows may use them as general study guides as they prepare for exams. Please note-the drafts are not final and may be updated following feedback. #pathboards https://t.co/YcNvTXsnLo

[Dan Graham @DanGrahamMD]

60s M posterior peripheral RLL lung mass. Pleural fluid cytology. Dx?

#PathX #PathTwitter #ThoracicPath

[ICCS_Education @ICCS_Education]

Immunophenotypic features of monocytic neoplasms.
From Xueyan Chen's talk at #FlowICCS24
#FlowEdu #Hemepath

[UCLA Pathology @UCLA_Pathology]

🏅 Congratulations to UCLA Pathology's Dr. Jonathan Said on receiving the The Berard-Dorfman Founders Award!

The Berard-Dorfman Founders Award was established in 2013 to commemorate Drs. Costan W. Berard, and Ronald F. Dorfman, who co-founded the Society for Hematopathology (SH) in 1981. Eligible recipients are mid-career to senior individuals who have demonstrated excellence in any or all areas of hematopathology including teaching, humanitarian contributions, and leadership.

Dr. Said was awarded this honor at the European Association for Hematopathology conference in Dubrovnik, Croatia.

#pathology #path2path #PathTwitter #PathX #Hemepath @SocforHemepath

[UCLA Pathology @UCLA_Pathology]

#WellnessWednesday: Paint & Sip Edition! 🍷🎨

Our residents had a fantastic time unwinding and getting creative at a recent paint and sip wellness event! It was the perfect opportunity to relax, bond, and tap into their artistic sides. 🖌️✨

#UCLAPathology #ResidentWellness #ResidencyLife #PathologyTraining #WellnessMatters #PaintAndSip #WellnessEvent #PathMatch #Pathology #path2path #PathTwitter #PathX

[Blood Journals Portfolio @BloodPortfolio]

The follicular lymphoma tumor microenvironment at single-cell and spatial resolution
https://t.co/zSCmwcu1oq #immunobiologyandimmunotherapy #lymphoidneoplasia #reviewseries

[Syed Z. Ali @sza_jhcyto]

ARTISTIC pattern created by cytospinning a hemorrhagic pleural effusion.

[Giovanni Botten, MD, PhD @GioBotten]

@UCLA_Pathology @UCLAJCCC Congrats Dr. Rao!

[The PhD Place @ThePhDPlace]

The best way to make progress is to continuously show up for your research.

[SocforHemepath @SocforHemepath]

Congratulations to Dr. Jonathan Said of @UCLA_Pathology, recipient of the 2024 Berard-Dorfman Senior Leadership Award! The award recognizes someone who has demonstrated excellence in any or all areas of #hemepath including teaching, humanitarian contributions, and leadership.

[Anas Nasir @BloodScientist]

#MorphologyMonday

You're just finishing a weekend shift and a sample pops onto the haematology authorisation queue.

The analyser has given the following results:
WBC: 50.44
RBC: 2.71
Hb: 84g/L
PLT: 28
Neuts: 8.07
Lymphs: *****
Monos: *****
Eos: *****
Basos: *****

You look at the plot and notice the unicorn horn. What do the images show?

#OnlyCells #Underthescope #bloodfilm #haematology

[Nico Gagelmann @NicoGagelmann]

Hematologist's Mona Lisa

[Alex Xu @alexmxu_]

Hey spatial bio world, ya boy is a video editor now! Watch the Spatial Biology Symposium here!
https://t.co/kt6Z3HKduJ

Thanks @KenLauLab @OphirKlein @jleePSOC @rrockne @Lu_Wei8 and our less-online speakers, Amander Clark, Mike Hicks, Jenny Treweek, Will Wang, Shahab Asgharzadeh

[UCLA Health @UCLAHealth]

A new study led by Dr. Dennis Slamon at @UCLAJCCC was published in @NEJM. The study found that a drug already used to treat patients with late-stage cancer can also improve survival rates for those with earlier stages of the disease. Watch on @TODAYshow: https://t.co/JgafL96mTu

[Jonathan Zuckerman MD PhD @JZRenalPath]

Rare atypical "Alport-like" GBM remodeling which can be commonly seen with IgA nephropathy. These changes are usually very segmental. #renalpath #PathTwitter

[Giovanni Botten, MD, PhD @GioBotten]

@anueru432 @GIJamesMD @KZhuPath @PathJared Good questions! @anueru432

My understanding is their presence is documented, not so much the quantity.

These tend to be underrepresented in early stage CTCL, at least for mycosis fungoides variant (PMID:32554312), and can even emerge post-dupilumab treatment (PMID:36073768).

[Giovanni Botten, MD, PhD @GioBotten]

Pautrier microabscesses may be a distinguishing feature of cutaneous T cell lymphoma (CTCL). CTCL mimics other dermatoses. Clinical correlation, IHC, and molecular testing may be required for optimal diagnosis and management.

#hemepath #dermpath @GIJamesMD @KZhuPath @PathJared